Nanomedicines for Breast Cancer Theranostics

In recent years, the commercialization of nanomedicine drugs and products has steadily increased. Currently, more than 250 nanomedicine products are identified on the market and many others are under clinical development for different therapeutic areas, including in cancer, infectious diseases, diabetes, cardiovascular and neurodegenerative diseases. More than 80 nano products focus on cancer theranostics. Nanomedicines for Breast Cancer Theranostics addresses translational aspects and clinical perspectives of breast cancer nanomedicine from a multidisciplinary perspective. The book summarizes research efforts at the preclinical and clinical stage of nanostructures and nanomedicine for dealing with the important challenge of nanomedicine translation in breast cancer theranostics. This book is an important resource for those working in both academia and industry, focusing in the areas of biomaterials, biomedical engineering, drug delivery and oncology.